Diagnostic Accuracy of Cyst Fluid Amphiregulin in Pancreatic Cysts

Overview

Journal BMC Gastroenterol

Publisher Biomed Central

Specialty Gastroenterology

Date 2012 Feb 16

PMID 22333441

Citations 9

Authors

May T Tun

Reetesh K Pai

Shirley Kwok

Aiwen Dong

Aparna Gupta

Brendan C Visser

Jeff A Norton

George A Poultsides

Subhas Banerjee

Jacques Van Dam

Ann M Chen

Shai Friedland

Brennan A Scott

Rahul Verma

Anson W Lowe

Walter G Park

Affiliations

Soon will be listed here.

Abstract

Background: Accurate tests to diagnose adenocarcinoma and high-grade dysplasia among mucinous pancreatic cysts are clinically needed. This study evaluated the diagnostic utility of amphiregulin (AREG) as a pancreatic cyst fluid biomarker to differentiate non-mucinous, benign mucinous, and malignant mucinous cysts.

Methods: A single-center retrospective study to evaluate AREG levels in pancreatic cyst fluid by ELISA from 33 patients with a histological gold standard was performed.

Results: Among the cyst fluid samples, the median (IQR) AREG levels for non-mucinous (n = 6), benign mucinous (n = 15), and cancerous cysts (n = 15) were 85 pg/ml (47-168), 63 pg/ml (30-847), and 986 pg/ml (417-3160), respectively. A significant difference between benign mucinous and malignant mucinous cysts was observed (p = 0.025). AREG levels greater than 300 pg/ml possessed a diagnostic accuracy for cancer or high-grade dysplasia of 78% (sensitivity 83%, specificity 73%).

Conclusion: Cyst fluid AREG levels are significantly higher in cancerous and high-grade dysplastic cysts compared to benign mucinous cysts. Thus AREG exhibits potential clinical utility in the evaluation of pancreatic cysts.

Citing Articles

Flexible variable selection in the presence of missing data.

Williamson B, Huang Y Int J Biostat. 2024; 20(2):347-359.

PMID: 38348882 PMC: 11323294. DOI: 10.1515/ijb-2023-0059.

Digital spatial profiling of intraductal papillary mucinous neoplasms: Toward a molecular framework for risk stratification.

Iyer M, Shi C, Eckhoff A, Fletcher A, Nussbaum D, Allen P Sci Adv. 2023; 9(11):eade4582.

PMID: 36930707 PMC: 10022906. DOI: 10.1126/sciadv.ade4582.

Biochemical Intracystic Biomarkers in the Differential Diagnosis of Pancreatic Cystic Lesions.

Wietrzykowska-Grishanovich D, Pawlik E, Neubauer K Medicina (Kaunas). 2022; 58(8).

PMID: 35893110 PMC: 9331360. DOI: 10.3390/medicina58080994.

Biomarkers in the diagnosis of pancreatic cancer: Are we closer to finding the golden ticket?.

ONeill R, Stoita A World J Gastroenterol. 2021; 27(26):4045-4087.

PMID: 34326612 PMC: 8311531. DOI: 10.3748/wjg.v27.i26.4045.

Significance of Amphiregulin (AREG) for the Outcome of Low and High Grade Astrocytoma Patients.

Steponaitis G, Kazlauskas A, Skiriute D, Vaitkiene P, Skauminas K, Tamasauskas A J Cancer. 2019; 10(6):1479-1488.

PMID: 31031857 PMC: 6485216. DOI: 10.7150/jca.29282.

References

Laffan T, Horton K, Klein A, Berlanstein B, Siegelman S, Kawamoto S . Prevalence of unsuspected pancreatic cysts on MDCT. AJR Am J Roentgenol. 2008; 191(3):802-7. PMC: 2692243. DOI: 10.2214/AJR.07.3340. View

Fernandez-Del Castillo C, Targarona J, Thayer S, Rattner D, Brugge W, Warshaw A . Incidental pancreatic cysts: clinicopathologic characteristics and comparison with symptomatic patients. Arch Surg. 2003; 138(4):427-3; discussion 433-4. PMC: 4403874. DOI: 10.1001/archsurg.138.4.427. View

Walsh R, Vogt D, Henderson J, Hirose K, Mason T, Bencsath K . Management of suspected pancreatic cystic neoplasms based on cyst size. Surgery. 2008; 144(4):677-84. DOI: 10.1016/j.surg.2008.06.013. View

Wang Z, Hao Y, Lowe A . The adenocarcinoma-associated antigen, AGR2, promotes tumor growth, cell migration, and cellular transformation. Cancer Res. 2008; 68(2):492-7. DOI: 10.1158/0008-5472.CAN-07-2930. View

Brugge W, Lewandrowski K, Lee-Lewandrowski E, Centeno B, Szydlo T, Regan S . Diagnosis of pancreatic cystic neoplasms: a report of the cooperative pancreatic cyst study. Gastroenterology. 2004; 126(5):1330-6. DOI: 10.1053/j.gastro.2004.02.013. View

Lowe A, Olsen M, Hao Y, Lee S, Lee K, Chen X . Gene expression patterns in pancreatic tumors, cells and tissues. PLoS One. 2007; 2(3):e323. PMC: 1824711. DOI: 10.1371/journal.pone.0000323. View

Dong A, Gupta A, Pai R, Tun M, Lowe A . The human adenocarcinoma-associated gene, AGR2, induces expression of amphiregulin through Hippo pathway co-activator YAP1 activation. J Biol Chem. 2011; 286(20):18301-10. PMC: 3093902. DOI: 10.1074/jbc.M110.215707. View

Tanaka M, Chari S, Adsay V, Fernandez-Del Castillo C, Falconi M, Shimizu M . International consensus guidelines for management of intraductal papillary mucinous neoplasms and mucinous cystic neoplasms of the pancreas. Pancreatology. 2005; 6(1-2):17-32. DOI: 10.1159/000090023. View

Das A, Wells C, Nguyen C . Incidental cystic neoplasms of pancreas: what is the optimal interval of imaging surveillance?. Am J Gastroenterol. 2008; 103(7):1657-62. DOI: 10.1111/j.1572-0241.2008.01893.x. View

10.

Shao J, Sheng H . Amphiregulin promotes intestinal epithelial regeneration: roles of intestinal subepithelial myofibroblasts. Endocrinology. 2010; 151(8):3728-37. PMC: 2940516. DOI: 10.1210/en.2010-0319. View

11.

Pelaez-Luna M, Chari S, Smyrk T, Takahashi N, Clain J, Levy M . Do consensus indications for resection in branch duct intraductal papillary mucinous neoplasm predict malignancy? A study of 147 patients. Am J Gastroenterol. 2007; 102(8):1759-64. DOI: 10.1111/j.1572-0241.2007.01224.x. View

12.

Ramachandran V, Arumugam T, Wang H, Logsdon C . Anterior gradient 2 is expressed and secreted during the development of pancreatic cancer and promotes cancer cell survival. Cancer Res. 2008; 68(19):7811-8. PMC: 4429896. DOI: 10.1158/0008-5472.CAN-08-1320. View

13.

Berasain C, Garcia-Trevijano E, Castillo J, Erroba E, Lee D, Prieto J . Amphiregulin: an early trigger of liver regeneration in mice. Gastroenterology. 2005; 128(2):424-32. DOI: 10.1053/j.gastro.2004.11.006. View

14.

Rautou P, Levy P, Vullierme M, OToole D, Couvelard A, Cazals-Hatem D . Morphologic changes in branch duct intraductal papillary mucinous neoplasms of the pancreas: a midterm follow-up study. Clin Gastroenterol Hepatol. 2008; 6(7):807-14. DOI: 10.1016/j.cgh.2007.12.021. View

15.

Kang M, Jang J, Kim S, Lee K, Ryu J, Kim Y . Cyst growth rate predicts malignancy in patients with branch duct intraductal papillary mucinous neoplasms. Clin Gastroenterol Hepatol. 2010; 9(1):87-93. DOI: 10.1016/j.cgh.2010.09.008. View

16.

Jacobson B, Baron T, Adler D, Davila R, Egan J, Hirota W . ASGE guideline: The role of endoscopy in the diagnosis and the management of cystic lesions and inflammatory fluid collections of the pancreas. Gastrointest Endosc. 2005; 61(3):363-70. DOI: 10.1016/s0016-5107(04)02779-8. View

17.

Correa-Gallego C, Ferrone C, Thayer S, Wargo J, Warshaw A, Fernandez-Del Castillo C . Incidental pancreatic cysts: do we really know what we are watching?. Pancreatology. 2010; 10(2-3):144-50. PMC: 3214832. DOI: 10.1159/000243733. View

18.

Tanno S, Nakano Y, Nishikawa T, Nakamura K, Sasajima J, Minoguchi M . Natural history of branch duct intraductal papillary-mucinous neoplasms of the pancreas without mural nodules: long-term follow-up results. Gut. 2007; 57(3):339-43. DOI: 10.1136/gut.2007.129684. View

19.

Brugge W, Lauwers G, Sahani D, Fernandez-Del Castillo C, Warshaw A . Cystic neoplasms of the pancreas. N Engl J Med. 2004; 351(12):1218-26. DOI: 10.1056/NEJMra031623. View

20.

Ahmad N, Kochman M, Lewis J, Ginsberg G . Can EUS alone differentiate between malignant and benign cystic lesions of the pancreas?. Am J Gastroenterol. 2002; 96(12):3295-300. DOI: 10.1111/j.1572-0241.2001.05328.x. View